Balyasny Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-780,180
Closed -$21.1M 3268
2024
Q2
$21.1M Buy
+780,180
New +$16.2M 0.04% 585
2024
Q1
Sell
-43,119
Closed -$529K 3231
2023
Q4
$529K Buy
+43,119
New +$404K ﹤0.01% 1931
2022
Q4
Sell
-157,681
Closed -$7.1M 3333
2022
Q3
$7.1M Buy
+157,681
New +$6.78M 0.02% 839
2022
Q2
Sell
-288,072
Closed -$11.9M 3285
2022
Q1
$11.9M Buy
+288,072
New +$10.1M 0.04% 633
2021
Q2
Sell
-99,588
Closed -$5.04M 2456
2021
Q1
$5.04M Buy
+99,588
New +$5.54M 0.02% 694
2020
Q3
Sell
-5,569
Closed -$233K 1666
2020
Q2
$233K Buy
+5,569
New +$214K ﹤0.01% 1027

Other funds holding SILK

Balyasny Asset Management's SILK Position: Q3 2024 in Review

Balyasny Asset Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 780,180 shares — an estimated $21.1M sold.

Balyasny Asset Management first reported a position in SILK in Q2 2020 and held it in 6 quarters. The position peaked at $21.1M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Balyasny Asset Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 780,180 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $21.1M.
  • Balyasny Asset Management first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • Balyasny Asset Management's Silk Road Medical, Inc. Common Stock position peaked at $21.1M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Balyasny Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.